DENVER - The Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC) brings together companies, investors, strategic partners and senior executives to create partnerships within the industry.
The conference is Sept. 21 to 22 at the Brown Palace Hotel and will host 30 of the region's private and public life science companies.
"This is an opportunity for our best and brightest bioscience companies in Colorado and surrounding states to really pitch their technologies to venture capitalists and strategic partners around the country for tracked money," Holli Riebel, president and CEO of the Colorado BioScience Association, said.
Colorado and the Rocky Mountain Region are among the top innovators in the bioscience field. Colorado, which employs over 17,000 people in bioscience, ranks in the top 10 in the number of financing deals and money raised in the field.
Positions in bioscience vary and can range from lab technicians to microbiologists and outside sales positions.
Some of the companies that will participate in the conference are Aurora-based PeptiVir, which is developing a vaccine for a universal flu shot, and Fort Collins-based VetDC, which is working with CSU to develop a cancer drug for dogs.
Another featured company is developing a technology to help soldiers on the battlefield.
"This [technology] allows [doctors] to put a sensor on a soldier's finger and determine whether they are at risk of cardiovascular collapse, and then they can determine which soldier needs to be transported to a hospital first," Riebel said.
For more information on the conference and the Colorado BioScience Association, visit http://www.cobioscience.com/.
(KUSA-TV © 2011 Multimedia Holdings Corporation)
You Might Be Interested In